American Well Corporation (AMWL)
Market Cap | 113.67M |
Revenue (ttm) | 269.78M |
Net Income (ttm) | -124.52M |
Shares Out | 15.81M |
EPS (ttm) | -8.02 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 60,581 |
Open | 7.06 |
Previous Close | 7.06 |
Day's Range | 7.05 - 7.33 |
52-Week Range | 6.10 - 12.95 |
Beta | 1.28 |
Analysts | Hold |
Price Target | 9.17 (+27.54%) |
Earnings Date | Aug 5, 2025 |
About AMWL
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers spec... [Read more]
Financial Performance
In 2024, American Well's revenue was $254.36 million, a decrease of -1.81% compared to the previous year's $259.05 million. Losses were -$208.14 million, -69.17% less than in 2023.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for AMWL stock is "Hold." The 12-month stock price target is $9.17, which is an increase of 27.54% from the latest price.
News

American Well Q2 Review: Hold Rating Maintained Amid DHA Renewal Concerns
American Well's revenue growth and cost control are strong, but the short DHA contract extension raises concerns about long-term stability and reliability of key revenue streams. Amwell's shift to hig...

Amwell makes grant to new employees under inducement plan
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 7...

American Well Corporation (AMWL) Q2 2025 Earnings Call Transcript
American Well Corporation (NYSE:AMWL) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Ido Schoenberg - Chairman & CEO Mark J. Hirschhorn - Executive VP, COO & CFO Sue ...

Amwell® Announces Results for Second Quarter 2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the seco...

Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extensi...

Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 o...

Amwell makes grant to new employee under inducement plan
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class ...

American Well Corporation (AMWL) Q1 2025 Earnings Call Transcript
American Well Corporation (NYSE:AMWL) Q1 2025 Results Conference Call May 1, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive O...

Amwell® Announces Results for First Quarter 2025
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first ...

Amwell® to participate in upcoming investor conferences
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the followi...

Amwell® to report first quarter 2025 operating results
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. F...

Amwell makes inducement grant
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) coveri...

Amwell announces innovation leader as chief product and technology officer
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company's new chi...

Amwell® makes grants to new employees under inducement plan
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16...

Amwell® to participate in upcoming investor conference
BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor confe...

American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Exec...

Amwell® Announces Results for Fourth Quarter and Full Year 2024
BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the four...

Amwell® to report fourth quarter and full year 2024 operating results
BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12.

Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced that Vida Health, a leader in virtual cardiometabolic care, is now part of t...

Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
Divestment of Amwell Psychiatric Care intended to focus product portfolio on key growth initiatives Company reiterates guidance for 2024 BOSTON, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL)...

Amwell CFO Mark Hirschhorn Expands Leadership Role
BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, has announced Chief Financial Officer (CFO) Mark Hirschhorn will take on an expanded role as chief operating...

American Well Corporation (AMWL) Q3 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Exe...

Amwell to participate in upcoming investor conferences
BOSTON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, announced company leaders will participate in several upcoming investor conferences. Ido Schoenberg, M.D.

Amwell announces new chief financial officer
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeedin...

Amwell to report third quarter 2024 operating results
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report third quarter 2024 operating results on Wednesday, Oct. 30. Following the distribution of the ear...